H

Helex Bio

22 employees

Enabling Safer Gene Editing

Basic info

Industry

biotechnology research

Sectors

Biotechnology
gRNA
Post experimental analysis
Custom Analysis Pipeline
cell specific editing
gRNA design
rare diseases
multi-omics
NGS
Variant Analysis
Genetics
Sanger Sequencing
Genomics
CRISPR Analyisis
CRO
De Novo Genome Assembly
3D spatial structures
bioinformatics
gene editing
genetic medicines drug design
Bioinformatics
AI/ ML
Sequencing
Molecular Biology
CRISPR
epigenetics

Date founded

2021

Funding rounds raised

Total raised

$1.1M

from 6 investors over 6 rounds

H

Helex Bio raised undisclosed on October 17, 2022

Investors: IndieBio and SOSV - The Accelerator VC

H

Helex Bio raised $1.1M on August 31, 2021

Investors: IndieBio and SOSV - The Accelerator VC

H

Helex Bio raised undisclosed on August 31, 2021

Investors: IndieBio and SOSV - The Accelerator VC

FAQ